Endy Weidinger

780 total citations · 1 hit paper
7 papers, 47 citations indexed

About

Endy Weidinger is a scholar working on Neurology, Physiology and Cognitive Neuroscience. According to data from OpenAlex, Endy Weidinger has authored 7 papers receiving a total of 47 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Neurology, 3 papers in Physiology and 2 papers in Cognitive Neuroscience. Recurrent topics in Endy Weidinger's work include Alzheimer's disease research and treatments (3 papers), Parkinson's Disease Mechanisms and Treatments (2 papers) and Down syndrome and intellectual disability research (1 paper). Endy Weidinger is often cited by papers focused on Alzheimer's disease research and treatments (3 papers), Parkinson's Disease Mechanisms and Treatments (2 papers) and Down syndrome and intellectual disability research (1 paper). Endy Weidinger collaborates with scholars based in Germany, Switzerland and United Kingdom. Endy Weidinger's co-authors include Sabrina Katzdobler, Carla Palleis, Daniela Krause, Günter U. Höglinger, Johannes Levin, Norbert Müller, Markus Schwarz, Henryk Barthel, Robert Perneczky and Adrian Danek and has published in prestigious journals such as Acta Neuropathologica, Movement Disorders and Frontiers in Aging Neuroscience.

In The Last Decade

Endy Weidinger

6 papers receiving 47 citations

Hit Papers

A quantitative Lewy-fold-specific alpha-synuclein seed am... 2025 2026 2025 4 8 12

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Endy Weidinger Germany 4 17 16 14 12 9 7 47
Maximilian Scheifele Germany 5 14 0.8× 17 1.1× 18 1.3× 16 1.3× 17 1.9× 12 64
Adeline Rollin France 3 10 0.6× 35 2.2× 30 2.1× 6 0.5× 18 2.0× 6 84
Lucas Scárdua Silva Brazil 4 42 2.5× 10 0.6× 5 0.4× 5 0.4× 5 0.6× 10 67
Babak Soleimani United Kingdom 5 26 1.5× 4 0.3× 8 0.6× 8 0.7× 16 1.8× 8 93
John Bertelson United States 4 22 1.3× 5 0.3× 8 0.6× 26 2.2× 9 1.0× 7 55
Abbas Walji United States 2 9 0.5× 25 1.6× 23 1.6× 4 0.3× 15 1.7× 3 47
Malin Löwenmark Sweden 5 33 1.9× 3 0.2× 24 1.7× 40 3.3× 10 1.1× 7 82
Arian Tavasol Iran 4 13 0.8× 8 0.5× 20 1.4× 8 0.7× 16 1.8× 21 99
Ana Belén Pastor Spain 3 5 0.3× 3 0.2× 20 1.4× 3 0.3× 10 1.1× 3 45
Andrew Frank Canada 4 18 1.1× 12 0.8× 36 2.6× 8 0.7× 37 4.1× 7 87

Countries citing papers authored by Endy Weidinger

Since Specialization
Citations

This map shows the geographic impact of Endy Weidinger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Endy Weidinger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Endy Weidinger more than expected).

Fields of papers citing papers by Endy Weidinger

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Endy Weidinger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Endy Weidinger. The network helps show where Endy Weidinger may publish in the future.

Co-authorship network of co-authors of Endy Weidinger

This figure shows the co-authorship network connecting the top 25 collaborators of Endy Weidinger. A scholar is included among the top collaborators of Endy Weidinger based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Endy Weidinger. Endy Weidinger is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

7 of 7 papers shown
1.
Palleis, Carla, Alexander Bernhardt, Endy Weidinger, et al.. (2025). A Biomarker‐Based Classification of Corticobasal Syndrome. Movement Disorders. 41(1). 129–142. 1 indexed citations
2.
Bernhardt, Alexander, Sebastian Longen, Svenja V. Trossbach, et al.. (2025). A quantitative Lewy-fold-specific alpha-synuclein seed amplification assay as a progression marker for Parkinson’s disease. Acta Neuropathologica. 149(1). 20–20. 13 indexed citations breakdown →
3.
Bernhardt, Alexander, Sigrun Roeber, Viktoria Ruf, et al.. (2025). Co-occurrence of multiple pathologies in a case of frontotemporal dementia with TBK1 mutation: first in vivo detection of alpha-synuclein and tau co-pathology. Acta Neuropathologica Communications. 13(1). 163–163.
4.
Loosli, Sandra, Elisabeth Wlasich, Catharina Prix, et al.. (2024). Measurement properties of the German version of the Cambridge examination for mental disorders of older people with Down syndrome and others with intellectual disabilities (CAMDEX-DS). Journal of Intellectual & Developmental Disability. 49(4). 402–414. 3 indexed citations
5.
Schönecker, Sonja, Carla Palleis, Nicolai Franzmeier, et al.. (2023). Symptomatology in 4-repeat tauopathies is associated with data-driven topology of [18F]-PI-2620 tau-PET signal. NeuroImage Clinical. 38. 103402–103402. 10 indexed citations
6.
Schmitt, Julia, Carla Palleis, Julia Sauerbeck, et al.. (2021). Dual-Phase β-Amyloid PET Captures Neuronal Injury and Amyloidosis in Corticobasal Syndrome. Frontiers in Aging Neuroscience. 13. 661284–661284. 12 indexed citations
7.
Müller, Norbert, Daniela Krause, Endy Weidinger, & Markus Schwarz. (2014). Immunologische Behandlungsoptionen bei schizophrenen Störungen. Fortschritte der Neurologie · Psychiatrie. 82(4). 210–219. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026